Bitte benutzen Sie diese Referenz, um auf diese Ressource zu verweisen: doi:10.22028/D291-37521
Volltext verfügbar? / Dokumentlieferung
Titel: Electronic cigarettes : a task force report from the European Respiratory Society
VerfasserIn: Bals, Robert
Boyd, Jeanette
Esposito, Susanna
Foronjy, Robert
Hiemstra, Pieter S.
Jiménez-Ruiz, Carlos A.
Katsaounou, Paraskevi
Lindberg, Anne
Metz, Carlos
Schober, Wolfgang
Spira, Avrum
Blasi, Francesco
Sprache: Englisch
Erscheinungsjahr: 2019
DDC-Sachgruppe: 610 Medizin, Gesundheit
Dokumenttyp: Sonstiges
Abstract: There is a marked increase in the development and use of electronic nicotine delivery systems or electronic cigarettes (ECIGs). This statement covers electronic cigarettes (ECIGs), defined as “electrical devices that generate an aerosol from a liquid” and thus excludes devices that contain tobacco. Database searches identified published articles that were used to summarise the current knowledge on the epidemiology of ECIG use; their ingredients and accompanied health effects; second-hand exposure; use of ECIGs for smoking cessation; behavioural aspects of ECIGs and social impact; in vitro and animal studies; and user perspectives. ECIG aerosol contains potentially toxic chemicals. As compared to conventional cigarettes, these are fewer and generally in lower concentrations. Second-hand exposures to ECIG chemicals may represent a potential risk, especially to vulnerable populations. There is not enough scientific evidence to support ECIGs as an aid to smoking cessation due to a lack of controlled trials, including those that compare ECIGs with licenced stop-smoking treatments. So far, there are conflicting data that use of ECIGs results in a renormalisation of smoking behaviour or for the gateway hypothesis. Experiments in cell cultures and animal studies show that ECIGs can have multiple negative effects. The long-term effects of ECIG use are unknown, and there is therefore no evidence that ECIGs are safer than tobacco in the long term. Based on current knowledge, negative health effects cannot be ruled out.
DOI der Erstveröffentlichung: 10.1183/13993003.01151-2018
URL der Erstveröffentlichung: https://erj.ersjournals.com/content/53/2/1801151
Link zu diesem Datensatz: urn:nbn:de:bsz:291--ds-375219
hdl:20.500.11880/33940
http://dx.doi.org/10.22028/D291-37521
Datum des Eintrags: 7-Okt-2022
Bemerkung/Hinweis: European Respiratory Journal 2019 53: 1801151
Fakultät: M - Medizinische Fakultät
Fachrichtung: M - Innere Medizin
Professur: M - Prof. Dr. Robert Bals
Sammlung:SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Dateien zu diesem Datensatz:
Es gibt keine Dateien zu dieser Ressource.


Alle Ressourcen in diesem Repository sind urheberrechtlich geschützt.